Endo M. Construction of heavy ion accelerator in Chiba (HIMAC) and its consequences—from medical physics viewpoint: part 1. Period until treatment Start (1975–1994). Jpn J Med Phys. 2020;40:61–7 (in Japanese).

Google Scholar 

Endo M. Construction of Heavy Ion Accelerator in Chiba (HIMAC) and its consequences—from medical physics viewpoint: part 2. Advancement of broad beam irradiation and development of a new compact-sized therapy accelerator (1994–2010). Jpn J Med Phys. 2020;40:97–105 (in Japanese).

Google Scholar 

Endo M. Construction of Heavy Ion Accelerator in Chiba (HIMAC) and its consequences—from medical physics viewpoint: part 3. Development of scanning irradiation and construction of new facility (2006–). Jpn J Med Phys. 2020;40:126–38 (in Japanese).

Google Scholar 

Endo M. Construction of Heavy Ion Accelerator in Chiba (HIMAC) and its consequences—from medical physics viewpoint: part 4. Outline of clinical research and future prospects. Jpn J Med Phys. 2021;41:10–21 (in Japanese).

Google Scholar 

Endo M. Creation, evolution, and future challenges of ion beam therapy from a medical physicist’s viewpoint (Part 1). Introduction and Chapter 1. Accelerator and beam delivery system. Radiol Phys Technol. 2022;15:271–90.

Article  PubMed  Google Scholar 

Endo M. Creation, evolution, and future challenges of ion beam therapy from a medical physicist’s viewpoint (Part 2)—Chapter 2. Bio-physical model and treatment planning system. Radiol Phys Technol. 2023;16:137–59.

Article  PubMed  Google Scholar 

International Commission on Radiation Units and Measurements. ICRU Report 93. Prescribing, recording, and reporting light ion beam therapy. J ICRU. 2019;16(1–2). https://www.icru.org/report/icru-report-93-prescribing-recording-and-reporting-light-ion-beam-therapy/. Accessed 27 Sept 2023.

Endo M. Robert R. Wilson (1914–2000): the first scientist to propose particle therapy—use of particle beam for cancer treatment. Radiol Phys Technol. 2018;11:1–6.

Article  PubMed  Google Scholar 

Alonso JR, Castro JR. light-ion therapy in the US: from the Bevalac to??. In: XVI Congress of Health Econometrics of the IAEA, Ajaccio, France, 9–11 Oct 2002. https://www.osti.gov/servlets/purl/803872. Accessed 23 Oct 2023.

Particle therapy cooperation group. Patient statistics. https://ptcog.site/images/Statistics/Patientstatistics-updateDec2021Sep6.2022provisional.pdf. Accessed 27 Sept 2023.

Linstadt DE, Castro JR, Philips T. Neon ion radiotherapy: results of the phase I/II clinical trial. Int J Radiat Oncol Biol Phys. 1991;20:761–9.

Article  CAS  PubMed  Google Scholar 

Castro JR, Linstadt DE, Bahary J-P, et al. Experience in charge particle irradiation of tumors of the skull base: 1977–1992. Int J Radiat Oncol Biol Phys. 1994;29:647–55.

Article  CAS  PubMed  Google Scholar 

Munzenrider JE, Austin-Seymour M, Blitzer PJ, et al. Proton therapy at Harvard. Strahlentherapie. 1985;161:756–63.

CAS  PubMed  Google Scholar 

Austin-Seymour M, Munzenrider J, Goitein M, et al. Fractionated proton radiation therapy of chordoma and low-grade chondrosarcoma of the base of the skull. J Neurosurg. 1989;70:13–7.

Article  CAS  PubMed  Google Scholar 

Austin-Seymour M, Munzenrider JE, Goitein M, et al. Progress in low LET heavy particle therapy: intracranial and paracranial tumors and uveal melanomas. Radiat Res. 1985;104:S219–26.

Article  Google Scholar 

Slater JD, Yonemoto LT, Rossi CJ Jr, et al. Conformal proton therapy for prostate carcinoma. Int J Radiat Oncol Biol Phys. 1998;42:299–304.

Article  CAS  PubMed  Google Scholar 

Fukumoto S. Proton beam therapy at Tsukuba. Proc of a Medical Workshop on Accelerators for Charged-Particle Beam Therapy, pp. 1–5, Fermilab, January 1985. https://lss.fnal.gov/conf/C850125/pg1.pdf. Accessed 23 Oct 2023.

Tsuji H, Tsujii H, Okumura T, et al. Preliminary results of proton radiotherapy at the Proton Medical Research Center, Tsukuba. J JASTRO. 1995;7:303–13. https://doi.org/10.11182/jastro1989.7.303 (in Japanese).

Article  Google Scholar 

Tsujii T. Radiotherapy Research. In: National Institute of Radiological Sciences (NIRS), editor. 50-year history of the National Institute of Radiological Sciences. Chiba: NIRS; 2007. p. 155–205 (in Japanese).

Sone S, Takashima S, Li F, et al. Mass screening for lung cancer with mobile spiral computed tomography scanner. Lancet. 1998;351:1242–5.

Article  CAS  PubMed  Google Scholar 

Withers HR, Taylor JMG, Maciejewski B. Treatment volume and tissue tolerance. Int J Radiat Oncol Biol Phys. 1998;14:751–9.

Article  Google Scholar 

Ando K, Koike S, Nojima K, et al. Mouse skin damages caused by fractionated irradiation with carbon ions. Int J Radiat Biol. 1998;74:129–38.

Article  CAS  PubMed  Google Scholar 

Koike S, Ando K, Oohara C, et al. Relative biological effectiveness of 290 MeV/u carbon ions for the growth delay of a radioresistant murine fibrosarcoma. J Radiat Res. 2002;43:247–55.

Article  PubMed  Google Scholar 

Ando K, Koike S, Uzawa A, et al. Biological gain of carbon-ion radiotherapy for the early response of tumor growth delay and against early response of skin reaction in mice. J Radiat Res. 2005;46:51–7.

Article  PubMed  Google Scholar 

Japanese Society for Radiation Oncology: Indications and unified treatment policy for particle beam therapy (proton beam therapy, heavy ion beam therapy) as advanced medical care. 2016. https://www.jastro.or.jp/medicalpersonnel/particle_beam/2016/02/post-2.html. Accessed 27 Sept 2023 (in Japanese).

Patel SH, Wang Z, Wong WW, et al. Charged particle therapy versus photon therapy for paranasal sinus and nasal cavity malignant diseases: a systematic review and meta-analysis. Lancet Oncol. 2014;15:1027–38.

Article  CAS  PubMed  Google Scholar 

Koto M, Demizu Y, Saitoh JI, et al. Japan Carbon-ion Radiation Oncology Study Group, Multicenter study of carbon-ion radiation therapy for mucosal melanoma of the head and neck: Subanalysis of the Japan Carbon-ion Radiation Oncology Study Group study. Int J Radiat Oncol Biol Phys. 2017;97:1054–60.

Article  PubMed  Google Scholar 

Sulaiman NS, Demizu Y, Koto M, et al. Multicenter study of carbon-ion radiation therapy for adenoid cystic carcinoma of the head and neck: subanalysis of the Japan Carbon-Ion Radiation Oncology Study Group (J-CROS) Study (1402 HN). Int J Radiat Oncol Biol Phys. 2018;100:639–46.

Article  Google Scholar 

Matsunobu A, Imai R, Kamada T, et al. Impact of carbon ion radiotherapy for unresectable osteosarcoma of the trunk. Cancer. 2012;118:4555–63.

Article  PubMed  Google Scholar 

Imai R, Kamada T, Araki N, Abe S, et al. Working Group for Bone and Soft Tissue Sarcomas, Carbon ion radiation therapy for unresectable sacral chordoma: an analysis of 188 cases. Int J Radiat Oncol Biol Phys. 2016;295:322–7.

Article  Google Scholar 

Yolcu YU, Jad Z, Wahood W, et al. Comparison of oncologic outcomes and treatment-related toxicity of carbon ion radiotherapy and en Bloc resection for sacral chordoma. JAMA Network Open. 2022;5(1):e2141927.

Article  PubMed  PubMed Central  Google Scholar 

Japan Society for Head and Neck Cancer. Report of head and neck cancer registry of Japan—clinical statistics of registered patients, 2019. 2022. http://www.jshnc.umin.ne.jp. HNCreport_2019. Accessed 27 Sept 2023.

National Cancer Center. Cancer type statistical information. https://ganjoho.jp/reg_stat/statistics/stat/cancer/index.html. Accessed 27 Sept 2023 (in Japanese).

National Cancer Center. Description of various rare cancers. https://www.ncc.go.jp/jp/rcc/about/. Accessed 27 Sept 2023 (in Japanese).

Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN Estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.

Article  PubMed  Google Scholar 

Miyamoto T, Baba M, Yamamoto N, et al. Curative treatment of stage I non-small-cell lung cancer with carbon ion beams using a hypo-fractionated regimen. Int J Radiat Oncol Biol Phys. 2007;67:750–8.

Article  CAS  PubMed  Google Scholar 

Miyamoto T, Baba M, Sugane T, et al. Carbon ion radiotherapy for stage I non-small cell lung cancer using a regimen of four fractions during 1 week. J Thorac Oncol. 2007;2:916–26.

Article  PubMed  Google Scholar 

Yamamoto N, Miyamoto T, Nakajima M, et al. A dose escalation clinical trial of single-fraction carbon ion radiotherapy for peripheral stage I non-small cell lung cancer. J Thorac Oncol. 2017;12:673–80.

Article  PubMed  Google Scholar 

Ono T, Yamamoto N, Nomoto A, et al. Long term results of single-fraction carbon-ion radiotherapy for non-small cell lung cancer. Cancers (Basel). 2021;13(1):112.

Article  CAS  Google Scholar 

Siva S, Ball DL. Single fraction SBRT for early stage lung cancer—less is more? Int J Radiat Oncol Biol Phys. 2019;103:1085–7.

Article  PubMed  Google Scholar 

Endo M. History of medical physics. Radiol Phys Technol. 2021;14:345–57.

Article  PubMed  Google Scholar 

Nagata Y, Hiraoka M, Shibata T, et al. A Prospective trial of stereotactic body radiation therapy for both operable and inoperable T1N0M0 non-small cell lung cancer: Japan Clinical Oncology Group Study JCOG0403. Int J Radiat Oncol Biol Phys. 2015;93:989–96.

Article  PubMed  Google Scholar 

Onishi H, Shirato H, Nagata Y, et al. Stereotactic body radiotherapy (SBRT) for operable stage I non-small cell lung cancer: can SBRT be comparable to surgery? Int J Radiat Oncol Biol Phys. 2011;81:1352–8.

Article  PubMed  Google Scholar 

Ohnishi K, Nakamura N, Harada H, et al. Proton beam therapy for histologically or clinically diagnosed stage I non-small cell lung cancer (NSCLC): the first nationwide retrospective study in Japan. Int J Radiat Oncol Biol Phys. 2020;106:82–9.

Article  CAS  PubMed  Google Scholar 

Okami J, Shintani Y, Okumura M, et al. Demographics, safety and quality, and prognostic information in both the seventh and eighth editions of the TNM classification in 18,973 surgical cases of the Japanese Joint Committee of Lung Cancer Registry Database in 2010. J Thorac Oncol. 2019;14:212–22.

Article  PubMed  Google Scholar 

Anzai M, Yamamoto N, Hayashi K, et al. Safety and efficacy of carbon-ion radiotherapy alone for stage ΙΙΙ non-small cell lung cancer. Anticancer Res. 2020;40:379–86.

Article  CAS  PubMed  Google Scholar 

Bradley JD, Paulus R, Komaki R, et al. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG0617): a randomised, two-by-two factorial phase 3 study. Lancet Oncol. 2015;162:187–99.

Article  Google Scholar